Published on 23 Feb 2024 on Zacks via Yahoo Finance
Amedisys, Inc. AMED reported adjusted earnings per share (EPS) of 94 cents in the fourth quarter of 2023, plunging 18.9% from the year-ago quarter’s figure of $1.16 per share. The bottom line missed the Zacks Consensus Estimate by 9.6%.
The quarter’s adjustments include certain merger related expenses, clinical optimization and CEO transition costs.
GAAP EPS in the fourth quarter was 59 cents, in line with the year-ago figure of 97 cents.